Early-life mtDNA mutations sufficient to drive age-related pathology, mouse study finds

Researchers have posted a preprint to bioRxiv reporting a new mouse model that allows mitochondrial mutagenesis to be confined to a defined developmental window. Using this system, the team found that mutations in the mitochondrial genome (mtDNA) introduced during the first two months of life were sufficient to drive a wide variety of age-related pathologies later in life — a finding the authors describe as surprising given existing uncertainty about the timing of mutagenic events that underlie physiological decline.

The study also reports that the severity of pathology is regulated in a broadly tissue-specific manner, suggesting that distinct selective pressures operate across organ systems as mtDNA mutations accumulate. The model offers a tool to dissect the temporal origins of mitochondrial contributions to ageing without the confound of lifetime mutation accumulation.

The work is a preprint and has not yet undergone peer review. The mechanisms by which early mtDNA mutations escape clearance by mitophagy and quality-control pathways to exert late-life effects remain to be clarified. Researchers in mitochondrial biology, ageing genetics, and disease modelling may find the mouse model of particular interest as a resource for future studies.